Integrative Basis of Cardiovascular Disease
joint with Molecular Pathways in Cardiac Development and Disease
Organizer(s): Andrew R. Marks, Stefanie Dimmeler and Ketty SchwartzDate: January 22 - 27, 2007
Location: Beaver Run Resort, Breckenridge, CO, USA
The most exciting research in cardiovascular biology these days is that designed to elucidate molecular mechanisms of complex diseases. These studies are leading to identification of novel therapeutic targets that can be tested in relevant animal models. Through the use of chemical genomics, small molecules that modulate gene function can be identified. These serve as precursors to novel therapeutics that can be developed for clinical use, in partnership with the pharmaceutical industry. Novel interfaces for cardiovascular biology include neurologic control, cell and tissue engineering and biomaterials (devices). The goal of this meeting is to address these opportunities and interfaces and create opportunities for cardiovascular scientists to interact with leaders in the fields of chemical genomics, tissue engineering and biomaterials, all with the aim of generating new ideas for cardiovascular science and therapeutics.
Scholarship Deadline: September 22 2006
Discounted Abstract Deadline: September 22 2006
Abstract Deadline: October 25 2006
Discounted Registration Deadline: November 22 2006
We gratefully acknowledge additional support for this conference from:
We gratefully acknowledge additional in-kind support for this conference from those foregoing speaker expense reimbursements:
Regeneron Pharmaceuticals, Inc.